$ELTP
ELITE PHARMACEUTICALS INC /NV/ Stock $eltp

$eltp Overview Financials Valuation SEC Filings Company Website

2013 Q4 Form 10-Q Financial Statement

#000114420414008935 Filed on February 14, 2014

Income Statement

Concept	2013 Q4	2012 Q4
Revenue	$1.693M	$667.7K
YoY Change	153.56%
Cost Of Revenue	$995.0K	$266.8K
YoY Change	272.95%
Gross Profit	$699.0K	$400.9K
YoY Change	74.36%
Gross Profit Margin	41.29%	60.04%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development	$1.291M	$238.3K
YoY Change	441.77%
% of Gross Profit	184.67%	59.43%
Depreciation & Amortization	$110.0K	$90.00K
YoY Change	22.22%	-25.0%
% of Gross Profit	15.74%	22.45%
Operating Expenses	$1.936M	$675.1K
YoY Change	186.77%
Operating Profit	-$1.237M	-$274.2K
YoY Change	351.11%
Interest Expense	$359.1K	$63.92K
YoY Change	461.81%
% of Operating Profit
Other Income/Expense, Net	$175.0K	$9.637M
YoY Change	-98.18%
Pretax Income	-$1.062M	$9.363M
YoY Change	-111.34%
Income Tax	$0.00
% Of Pretax Income
Net Earnings	-$1.062M	$9.363M
YoY Change	-111.34%
Net Earnings / Revenue	-62.73%	1402.34%
Basic Earnings Per Share	$0.00	$0.03
Diluted Earnings Per Share	$0.00	$0.00
COMMON SHARES
Basic Shares Outstanding	508.6M shares	350.2M shares
Diluted Shares Outstanding	508.6M shares	486.2M shares

Balance Sheet

Concept	2013 Q4	2012 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.080M	$70.00K
YoY Change	1442.86%	-87.72%
Cash & Equivalents	$1.081M	$65.66K
Short-Term Investments
Other Short-Term Assets	$280.0K	$70.00K
YoY Change	300.0%	16.67%
Inventory	$1.532M	$980.0K
Prepaid Expenses
Receivables	$1.024M	$530.0K
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$3.918M	$1.640M
YoY Change	138.89%	6.49%
LONG-TERM ASSETS
Property, Plant & Equipment	$4.117M	$4.110M
YoY Change	0.16%	-2.84%
Goodwill
YoY Change
Intangibles	$6.315M
YoY Change
Long-Term Investments	$3.360M	$3.340M
YoY Change	0.6%	0.0%
Other Assets	$560.0K	$590.0K
YoY Change	-5.08%	-1.67%
Total Long-Term Assets	$14.36M	$8.730M
YoY Change	64.48%	-0.91%
TOTAL ASSETS
Total Short-Term Assets	$3.918M	$1.640M
Total Long-Term Assets	$14.36M	$8.730M
Total Assets	$18.28M	$10.37M
YoY Change	76.25%	0.19%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.990M	$1.400M
YoY Change	42.14%	13.82%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$6.390M	$0.00
YoY Change
Long-Term Debt Due	$3.390M	$3.890M
YoY Change	-12.85%	14.41%
Total Short-Term Liabilities	$12.51M	$5.380M
YoY Change	132.44%	13.98%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$98.34K	$17.34M
YoY Change	-99.43%	-13.04%
Total Long-Term Liabilities	$10.70M	$17.34M
YoY Change	-38.3%	-13.04%
TOTAL LIABILITIES
Total Short-Term Liabilities	$12.51M	$5.380M
Total Long-Term Liabilities	$10.70M	$17.34M
Total Liabilities	$23.20M	$22.73M
YoY Change	2.09%	-7.83%
SHAREHOLDERS EQUITY
Retained Earnings	-$138.2M
YoY Change
Common Stock	$133.6M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)	$306.8K
YoY Change
Treasury Stock Shares	100.0K shares
Shareholders Equity	-$4.927M	-$12.36M
YoY Change
Total Liabilities & Shareholders Equity	$18.28M	$10.37M
YoY Change	76.25%	0.19%

Cashflow Statement

Concept	2013 Q4	2012 Q4
OPERATING ACTIVITIES
Net Income	-$1.062M	$9.363M
YoY Change	-111.34%
Depreciation, Depletion And Amortization	$110.0K	$90.00K
YoY Change	22.22%	-25.0%
Cash From Operating Activities	-$1.460M	-$330.0K
YoY Change	342.42%	-41.07%
INVESTING ACTIVITIES
Capital Expenditures	-$290.0K	-$30.00K
YoY Change	866.67%	-25.0%
Acquisitions
YoY Change
Other Investing Activities	-$30.00K	-$90.00K
YoY Change	-66.67%	-25.0%
Cash From Investing Activities	-$310.0K	-$120.0K
YoY Change	158.33%	-25.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	2.090M	300.0K
YoY Change	596.67%	-850.0%
NET CHANGE
Cash From Operating Activities	-1.460M	-330.0K
Cash From Investing Activities	-310.0K	-120.0K
Cash From Financing Activities	2.090M	300.0K
Net Change In Cash	320.0K	-150.0K
YoY Change	-313.33%	-80.26%
FREE CASH FLOW
Cash From Operating Activities	-$1.460M	-$330.0K
Capital Expenditures	-$290.0K	-$30.00K
Free Cash Flow	-$1.170M	-$300.0K
YoY Change	290.0%	-42.31%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2013Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	6314621	USD
CY2013Q1	us-gaap	Liabilities Current LiabilitiesCurrent	5357255	USD
CY2013Q4	us-gaap	Liabilities Current LiabilitiesCurrent	12505260	USD
CY2013Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	142223	USD
CY2013Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	98340	USD
CY2013Q1	eltp	Derivative Liability Preferred Shares DerivativeLiabilityPreferredShares	6334621	USD
CY2013Q4	eltp	Derivative Liability Preferred Shares DerivativeLiabilityPreferredShares	19200	USD
CY2013Q1	eltp	Derivative Liability Warrants DerivativeLiabilityWarrants	7862848	USD
CY2013Q4	eltp	Derivative Liability Warrants DerivativeLiabilityWarrants	10439126	USD
CY2013Q4	us-gaap	Common Stock Value CommonStockValue	513219	USD
CY2013Q1	us-gaap	Treasury Stock Value TreasuryStockValue	306841	USD
CY2013Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	11125133	USD
CY2013Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	320148	USD
CY2013Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	10698889	USD
CY2013Q4	us-gaap	Liabilities Liabilities	23204149	USD
CY2013Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	91571	USD
CY2013Q4	us-gaap	Inventory Net InventoryNet	1531645	USD
CY2013Q4	us-gaap	Assets Current AssetsCurrent	3917786	USD
CY2013Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	281065	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1080792	USD
CY2013Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	267820	USD
CY2013Q1	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	152223	USD
CY2013Q4	us-gaap	Assets Assets	18276723	USD
CY2013Q4	eltp	Short Term Loans And Current Portion Of Long Term Debt ShortTermLoansAndCurrentPortionOfLongTermDebt	1177	USD
CY2013Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1024284	USD
CY2013Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	151051	USD
CY2013Q1	us-gaap	Assets Current AssetsCurrent	2543374	USD
CY2013Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4028943	USD
CY2013Q4	us-gaap	Cost Method Investments CostMethodInvestments	3329322	USD
CY2013Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts	236300	USD
CY2013Q1	us-gaap	Security Deposit SecurityDeposit	14314	USD
CY2013Q1	us-gaap	Inventory Net InventoryNet	1358146	USD
CY2013Q4	us-gaap	Security Deposit SecurityDeposit	35083	USD
CY2013Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	327014	USD
CY2013Q1	us-gaap	Deferred Offering Costs DeferredOfferingCosts	246934	USD
CY2013Q1	us-gaap	Assets Assets	11125133	USD
CY2013Q1	us-gaap	Secured Debt Current SecuredDebtCurrent	3385000	USD
CY2013Q4	us-gaap	Secured Debt Current SecuredDebtCurrent	3385000	USD
CY2013Q1	eltp	Short Term Loans And Current Portion Of Long Term Debt ShortTermLoansAndCurrentPortionOfLongTermDebt	6296	USD
CY2013Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	665154	USD
CY2013Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	369023	USD
CY2013Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4116597	USD
CY2013Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-138209070	USD
CY2013Q4	us-gaap	Treasury Stock Value TreasuryStockValue	306841	USD
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	-4927426	USD
CY2013Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	18276723	USD
CY2013Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	133075266	USD
CY2013Q1	us-gaap	Liabilities Liabilities	19798518	USD
CY2013Q1	us-gaap	Common Stock Value CommonStockValue	374495	USD
CY2013Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	119690336	USD
CY2013Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-128431375	USD
CY2013Q1	us-gaap	Stockholders Equity StockholdersEquity	-8673385	USD
CY2013Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	14441263	USD
CY2013Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	694426	USD
CY2013Q1	us-gaap	Cost Method Investments CostMethodInvestments	3329322	USD
CY2013Q1	eltp	Assets Noncurrent Excluding Property Plant And Equipment And Intangible Assets AssetsNoncurrentExcludingPropertyPlantAndEquipmentAndIntangibleAssets	3858390	USD
CY2013Q4	eltp	Assets Noncurrent Excluding Property Plant And Equipment And Intangible Assets AssetsNoncurrentExcludingPropertyPlantAndEquipmentAndIntangibleAssets	3927719	USD
CY2013Q1	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	0	USD
CY2013Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	6067121	USD
CY2013Q1	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	600000	USD
CY2013Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1325126	USD
CY2013Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1990728	USD
CY2013Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	13333	USD
CY2013Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	13333	USD
CY2013Q1	eltp	Preferred Share Derivative Interest Payable PreferredShareDerivativeInterestPayable	27500	USD
CY2013Q4	eltp	Preferred Share Derivative Interest Payable PreferredShareDerivativeInterestPayable	480	USD
	dei	Trading Symbol TradingSymbol	ELTP
CY2014Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	527082097	shares
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2012Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	345384514	shares
CY2013Q1	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	0	USD
CY2013Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	USD
CY2013Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	USD
CY2013Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	93338	USD
CY2013Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	0	USD
CY2013Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	5068522	USD
CY2013Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	5391686	USD
CY2013Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	0	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	0	USD
CY2013Q1	eltp	Accumulated Amortization Eda Bond Offering Costs AccumulatedAmortizationEdaBondOfferingCosts	107519	USD
CY2013Q4	eltp	Accumulated Amortization Eda Bond Offering Costs AccumulatedAmortizationEdaBondOfferingCosts	118153	USD
CY2013Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	3932879	USD
CY2013Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2013Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2013Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	690000000	shares
CY2013Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	690000000	shares
CY2013Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	374493959	shares
CY2013Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	513217800	shares
CY2013Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	374393959	shares
CY2013Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	513117800	shares
CY2013Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	100000	shares
CY2013Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	100000	shares
CY2013Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-1237152	USD
CY2012Q4	us-gaap	Depreciation And Amortization DepreciationAndAmortization	40723	USD
CY2013Q4	us-gaap	Depreciation And Amortization DepreciationAndAmortization	126827	USD
	us-gaap	Operating Expenses OperatingExpenses	1955210	USD
	us-gaap	Operating Expenses OperatingExpenses	4282925	USD
	us-gaap	Interest Expense InterestExpense	183709	USD
	us-gaap	Interest Expense InterestExpense	689852	USD
CY2012Q4	us-gaap	Interest Expense InterestExpense	63924	USD
CY2013Q4	us-gaap	Interest Expense InterestExpense	359130	USD
	eltp	Change In Fair Value Of Warrant Derivatives ChangeInFairValueOfWarrantDerivatives	2770912	USD
	eltp	Change In Fair Value Of Warrant Derivatives ChangeInFairValueOfWarrantDerivatives	-2576278	USD
	us-gaap	Revenue Other Manufactured Products RevenueOtherManufacturedProducts	1246210	USD
	us-gaap	Revenue Other Manufactured Products RevenueOtherManufacturedProducts	2356619	USD
CY2012Q4	us-gaap	Revenue Other Manufactured Products RevenueOtherManufacturedProducts	400494	USD
CY2013Q4	us-gaap	Revenue Other Manufactured Products RevenueOtherManufacturedProducts	891838	USD
	us-gaap	Royalty Revenue RoyaltyRevenue	439117	USD
	us-gaap	Royalty Revenue RoyaltyRevenue	1147958	USD
CY2012Q4	us-gaap	Royalty Revenue RoyaltyRevenue	156454	USD
CY2013Q4	us-gaap	Royalty Revenue RoyaltyRevenue	743125	USD
	us-gaap	Contracts Revenue ContractsRevenue	195427	USD
CY2012Q4	us-gaap	Operating Expenses OperatingExpenses	675100	USD
CY2013Q4	us-gaap	Operating Expenses OperatingExpenses	1935816	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1275243	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2899322	USD
	us-gaap	Contracts Revenue ContractsRevenue	69255	USD
CY2012Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-274210	USD
CY2012Q4	us-gaap	Contracts Revenue ContractsRevenue	110734	USD
CY2013Q4	us-gaap	Contracts Revenue ContractsRevenue	58283	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	1880754	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	3573832	USD
CY2012Q4	us-gaap	Sales Revenue Net SalesRevenueNet	667682	USD
CY2013Q4	us-gaap	Sales Revenue Net SalesRevenueNet	1693246	USD
	us-gaap	Cost Of Revenue CostOfRevenue	1200787	USD
	us-gaap	Cost Of Revenue CostOfRevenue	2190229	USD
CY2012Q4	us-gaap	Cost Of Revenue CostOfRevenue	266792	USD
CY2013Q4	us-gaap	Cost Of Revenue CostOfRevenue	994582	USD
	us-gaap	Gross Profit GrossProfit	679967	USD
	us-gaap	Gross Profit GrossProfit	1383603	USD
CY2012Q4	us-gaap	Gross Profit GrossProfit	400890	USD
CY2013Q4	us-gaap	Gross Profit GrossProfit	698664	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	663625	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2715126	USD
CY2012Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	238268	USD
CY2013Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1290858	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1147112	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1143487	USD
CY2012Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	380976	USD
CY2013Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	494469	USD
	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	36379	USD
CY2013Q4	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	23662	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	108094	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	372227	USD
CY2012Q4	eltp	Change In Fair Value Of Warrant Derivatives ChangeInFairValueOfWarrantDerivatives	5765992	USD
CY2013Q4	eltp	Change In Fair Value Of Warrant Derivatives ChangeInFairValueOfWarrantDerivatives	656844	USD
	eltp	Change In Fair Value Of Preferred Share Derivatives ChangeInFairValueOfPreferredShareDerivatives	-867741	USD
	eltp	Change In Fair Value Of Preferred Share Derivatives ChangeInFairValueOfPreferredShareDerivatives	-3462104	USD
CY2012Q4	eltp	Change In Fair Value Of Preferred Share Derivatives ChangeInFairValueOfPreferredShareDerivatives	3963126	USD
CY2013Q4	eltp	Change In Fair Value Of Preferred Share Derivatives ChangeInFairValueOfPreferredShareDerivatives	4228	USD
	eltp	Interest Expense Preferred Share Derivatives InterestExpensePreferredShareDerivatives	111719	USD
	eltp	Interest Expense Preferred Share Derivatives InterestExpensePreferredShareDerivatives	40428	USD
CY2012Q4	eltp	Interest Expense Preferred Share Derivatives InterestExpensePreferredShareDerivatives	27818	USD
CY2013Q4	eltp	Interest Expense Preferred Share Derivatives InterestExpensePreferredShareDerivatives	-632	USD
	eltp	Discount In Series E Issuance Attributable To Beneficial Conversion Features DiscountInSeriesEIssuanceAttributableToBeneficialConversionFeatures	437500	USD
	eltp	Discount In Series E Issuance Attributable To Beneficial Conversion Features DiscountInSeriesEIssuanceAttributableToBeneficialConversionFeatures	0	USD
CY2012Q4	eltp	Discount In Series E Issuance Attributable To Beneficial Conversion Features DiscountInSeriesEIssuanceAttributableToBeneficialConversionFeatures	0	USD
CY2013Q4	eltp	Discount In Series E Issuance Attributable To Beneficial Conversion Features DiscountInSeriesEIssuanceAttributableToBeneficialConversionFeatures	0	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	19831	USD
CY2012Q4	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	USD
CY2013Q4	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1170243	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-6876104	USD
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	345384514	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	439720987	shares
CY2012Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	486207413	shares
CY2013Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	508638816	shares
CY2013Q2	eltp	Finite Lived Intangible Assets Acquired During Period FiniteLivedIntangibleAssetsAcquiredDuringPeriod	18498	USD
	eltp	Finite Lived Intangible Assets Acquired During Period FiniteLivedIntangibleAssetsAcquiredDuringPeriod	5620197	USD
CY2013Q3	eltp	Finite Lived Intangible Assets Acquired During Period FiniteLivedIntangibleAssetsAcquiredDuringPeriod	5601082	USD
CY2013Q4	eltp	Finite Lived Intangible Assets Acquired During Period FiniteLivedIntangibleAssetsAcquiredDuringPeriod	617	USD
CY2013Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	0	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	0	USD
CY2013Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	0	USD
CY2013Q4	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	0	USD
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	415500	USD
CY2012Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	9637376	USD
CY2013Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	175301	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-105000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-9775426	USD
CY2012Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	9363166	USD
CY2013Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1061851	USD
	us-gaap	Income Tax Credits And Adjustments IncomeTaxCreditsAndAdjustments	4023	USD
	us-gaap	Income Tax Credits And Adjustments IncomeTaxCreditsAndAdjustments	2269	USD
CY2012Q4	us-gaap	Income Tax Credits And Adjustments IncomeTaxCreditsAndAdjustments	0	USD
CY2013Q4	us-gaap	Income Tax Credits And Adjustments IncomeTaxCreditsAndAdjustments	0	USD
	us-gaap	Net Income Loss NetIncomeLoss	-109023	USD
	us-gaap	Net Income Loss NetIncomeLoss	-9777695	USD
CY2012Q4	us-gaap	Net Income Loss NetIncomeLoss	9363166	USD
CY2013Q4	us-gaap	Net Income Loss NetIncomeLoss	-1061851	USD
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2012Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
CY2013Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
CY2013Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	439720987	shares
CY2012Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	350220224	shares
CY2013Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	508638816	shares
CY2013Q1	eltp	Bond Issue Costs BondIssueCosts	354453	USD
CY2013Q4	eltp	Bond Issue Costs BondIssueCosts	354453	USD
CY2013Q4	eltp	Accumulated Amortization Of Bond AccumulatedAmortizationOfBond	118153	USD
CY2013Q1	eltp	Unamortization Of Bond UnamortizationOfBond	246934	USD
CY2013Q4	eltp	Unamortization Of Bond UnamortizationOfBond	236300	USD
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	3510000	USD
	eltp	Stock Issued During Period Value Payment For Preferred Share Derivative Interest StockIssuedDuringPeriodValuePaymentForPreferredShareDerivativeInterest	67449	USD
	eltp	Conversion Of Series B Series C And Series E Preferred Shares Into Common Shares Value ConversionOfSeriesBSeriesCAndSeriesEPreferredSharesIntoCommonSharesValue	9777524	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	52085	USD
	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	47987	USD
	eltp	Stock Issued During Period Value Payment Of Directors Fees StockIssuedDuringPeriodValuePaymentOfDirectorsFees	0	USD
	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	164583	USD
CY2013Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	8575	shares
CY2013Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	24	shares
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	87363	USD
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	89112	USD
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	90894	USD
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	435972	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	67753	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	67753	USD
CY2012Q4	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	22584	USD
CY2013Q4	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	22584	USD
CY2013Q4	eltp	Preferred Stock Conversion Shares PreferredStockConversionShares	160000	shares
CY2013Q4	eltp	Preferred Stock Closing Price PreferredStockClosingPrice	0.12
CY2013Q1	us-gaap	Derivative Fair Value Of Derivative Liability Amount Not Offset Against Collateral DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral	6334621	USD
CY2013Q4	us-gaap	Derivative Fair Value Of Derivative Liability Amount Not Offset Against Collateral DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral	19824	USD
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	83259	USD
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	85344	USD
	us-gaap	Payments To Acquire Other Property Plant And Equipment PaymentsToAcquireOtherPropertyPlantAndEquipment	110787	USD
	us-gaap	Payments To Acquire Other Property Plant And Equipment PaymentsToAcquireOtherPropertyPlantAndEquipment	379615	USD
	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	32801	USD
	eltp	Increase Decrease In Deferred Revenue And Customer Deposits IncreaseDecreaseInDeferredRevenueAndCustomerDeposits	-10000	USD
	eltp	Increase Decrease In Derivative Interest Payable Net IncreaseDecreaseInDerivativeInterestPayableNet	-43466	USD
	eltp	Increase Decrease In Derivative Interest Payable Net IncreaseDecreaseInDerivativeInterestPayableNet	-27020	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1466724	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2741608	USD
	us-gaap	Increase Decrease In Deferred Liabilities IncreaseDecreaseInDeferredLiabilities	7215	USD
	us-gaap	Increase Decrease In Deferred Liabilities IncreaseDecreaseInDeferredLiabilities	5698	USD
CY2012Q4	us-gaap	Increase Decrease In Deferred Liabilities IncreaseDecreaseInDeferredLiabilities	2403	USD
CY2013Q4	us-gaap	Increase Decrease In Deferred Liabilities IncreaseDecreaseInDeferredLiabilities	1899	USD
CY2013Q1	us-gaap	Deferred Rent Credit DeferredRentCredit	68260	USD
CY2013Q2	us-gaap	Deferred Rent Credit DeferredRentCredit	70160	USD
CY2013Q3	us-gaap	Deferred Rent Credit DeferredRentCredit	72062	USD
CY2013Q4	us-gaap	Deferred Rent Credit DeferredRentCredit	73961	USD
	eltp	Operating Lease Description OperatingLeaseDescription	initial term of 5 years and 6 months and the Company has the option to renew the lease for two additional terms, each of 5 years
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	330543	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	334277	USD
	us-gaap	Paid In Kind Interest PaidInKindInterest	155184	USD
	us-gaap	Paid In Kind Interest PaidInKindInterest	67449	USD
	eltp	Accrued Compensation Non Cash AccruedCompensationNonCash	190000	USD
	eltp	Accrued Compensation Non Cash AccruedCompensationNonCash	344500	USD
	eltp	Interest Expense Non Cash InterestExpenseNonCash	0	USD
	eltp	Interest Expense Non Cash InterestExpenseNonCash	469805	USD
	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	1008	USD
	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	1070	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	129539	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	359130	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	679549	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	173499	USD
	eltp	Increase Decrease In Prepaid And Other Current Assets IncreaseDecreaseInPrepaidAndOtherCurrentAssets	-62425	USD
	eltp	Increase Decrease In Prepaid And Other Current Assets IncreaseDecreaseInPrepaidAndOtherCurrentAssets	150783	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	137640	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	315980	USD
	eltp	Increase Decrease In Deferred Revenue And Customer Deposits IncreaseDecreaseInDeferredRevenueAndCustomerDeposits	40130	USD
	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	31682	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	40001	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	22878	USD
	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	62466	USD
	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	59194	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-246055	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-493369	USD
	eltp	Proceeds From Issuance Of Series E Convertible Preferred Stock ProceedsFromIssuanceOfSeriesEConvertiblePreferredStock	437500	USD
	eltp	Proceeds From Issuance Of Series E Convertible Preferred Stock ProceedsFromIssuanceOfSeriesEConvertiblePreferredStock	0	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	3510000	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	187500	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	164583	USD
	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	500000	USD
	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	320150	USD
	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	5117	USD
	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	0	USD
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	9856	USD
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	47987	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1110027	USD
	eltp	Commitment Shares Issued CommitmentSharesIssued	0	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3946746	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-602752	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	711769	USD
CY2012Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	668407	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	65655	USD
	us-gaap	Interest Paid InterestPaid	115623	USD
	us-gaap	Interest Paid InterestPaid	160680	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	4023	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	2269	USD
	eltp	Commitment Shares Issued CommitmentSharesIssued	320522	USD
	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	0	USD
	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	9777524	USD
	us-gaap	Noncash Or Part Noncash Acquisition Intangible Assets Acquired1 NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1	0	USD
	us-gaap	Noncash Or Part Noncash Acquisition Intangible Assets Acquired1 NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1	5597317	USD
	us-gaap	Notes Issued1 NotesIssued1	0	USD
	us-gaap	Notes Issued1 NotesIssued1	5597317	USD
CY2013Q4	eltp	Payments Received In Advance PaymentsReceivedInAdvance	200000	USD
CY2013Q1	eltp	Recognized Deferred Revenue RecognizedDeferredRevenue	34444	USD
	us-gaap	Deferred Revenue Revenue Recognized DeferredRevenueRevenueRecognized	10000	USD
CY2013Q4	us-gaap	Deferred Revenue DeferredRevenue	155556	USD
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	2203999	shares
CY2013Q4	eltp	Share Based Compensation Arrangement By Share Based Payment Award Non Vested Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonVestedOptionsOutstandingNumber	3540001	shares
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-109023	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-9777695	USD
CY2012Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	9363166	USD
CY2013Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1061851	USD
CY2012Q4	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-365952	USD
CY2012Q4	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	135987189	shares
CY2013Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	10000000	USD
CY2013Q4	eltp	Net Present Value Of Note NetPresentValueOfNote	5597317	USD
CY2013Q4	eltp	Finite Lived Intangible Assets Acquired Aggregate Cost FiniteLivedIntangibleAssetsAcquiredAggregateCost	5597317	USD
	us-gaap	Business Combination Consideration Transferred1 BusinessCombinationConsiderationTransferred1	10000000	USD
CY2013Q4	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.07
	us-gaap	Debt Instrument Convertible Number Of Equity Instruments DebtInstrumentConvertibleNumberOfEquityInstruments	14286	pure
	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	1000	USD
	dei	Document Type DocumentType	10-Q
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Period End Date DocumentPeriodEndDate	2013-12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2014
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Registrant Name EntityRegistrantName	ELITE PHARMACEUTICALS INC /NV/
	dei	Entity Central Index Key EntityCentralIndexKey	0001053369
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--03-31
	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	600000	USD
CY2013Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	0	USD
CY2013Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	727273	USD
	eltp	Change In Fair Value Of Convertible Note Derivative Instruments ChangeInFairValueOfConvertibleNoteDerivativeInstruments	-127273	USD
	eltp	Change In Fair Value Of Convertible Note Derivative Instruments ChangeInFairValueOfConvertibleNoteDerivativeInstruments	0	USD
CY2012Q4	eltp	Change In Fair Value Of Convertible Note Derivative Instruments ChangeInFairValueOfConvertibleNoteDerivativeInstruments	0	USD
CY2013Q4	eltp	Change In Fair Value Of Convertible Note Derivative Instruments ChangeInFairValueOfConvertibleNoteDerivativeInstruments	-127273	USD
CY2013Q4	eltp	Area Of Land Taken For Lease AreaOfLandTakenForLease	15000	sqft

Files In Submission

Name	View Source	Status
0001144204-14-008935-index-headers.html	Edgar Link	pending
0001144204-14-008935-index.html	Edgar Link	pending
0001144204-14-008935.txt	Edgar Link	pending
0001144204-14-008935-xbrl.zip	Edgar Link	pending
eltp-20131231.xml	Edgar Link	completed
eltp-20131231.xsd	Edgar Link	pending
eltp-20131231_cal.xml	Edgar Link	unprocessable
eltp-20131231_def.xml	Edgar Link	unprocessable
eltp-20131231_lab.xml	Edgar Link	unprocessable
eltp-20131231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
v366866_10q.htm	Edgar Link	pending
v366866_ex31-1.htm	Edgar Link	pending
v366866_ex31-2.htm	Edgar Link	pending
v366866_ex32-1.htm	Edgar Link	pending
v366866_ex32-2.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ELTP
ELITE PHARMACEUTICALS INC /NV/ Stock $eltp

2013 Q4 Form 10-Q Financial Statement

#000114420414008935 Filed on February 14, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ELTP ELITE PHARMACEUTICALS INC /NV/ Stock $eltp

2013 Q4 Form 10-Q Financial Statement

#000114420414008935 Filed on February 14, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ELTP
ELITE PHARMACEUTICALS INC /NV/ Stock $eltp